KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Non-Current Debt (2016 - 2026)

Abbott Laboratories' Non-Current Debt history spans 18 years, with the latest figure at $29.6 billion for Q1 2026.

  • On a quarterly basis, Non-Current Debt rose 132.71% to $29.6 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $29.6 billion, a 132.71% increase, with the full-year FY2025 number at $9.9 billion, down 21.62% from a year prior.
  • Non-Current Debt hit $29.6 billion in Q1 2026 for Abbott Laboratories, up from $9.9 billion in the prior quarter.
  • Over the last five years, Non-Current Debt for ABT hit a ceiling of $29.6 billion in Q1 2026 and a floor of $9.9 billion in Q4 2025.
  • Historically, Non-Current Debt has averaged $14.6 billion across 5 years, with a median of $13.6 billion in 2023.
  • Biggest five-year swings in Non-Current Debt: decreased 21.62% in 2025 and later surged 132.71% in 2026.
  • Tracing ABT's Non-Current Debt over 5 years: stood at $14.5 billion in 2022, then fell by 6.36% to $13.6 billion in 2023, then fell by 7.16% to $12.6 billion in 2024, then decreased by 21.62% to $9.9 billion in 2025, then soared by 199.49% to $29.6 billion in 2026.
  • Business Quant data shows Non-Current Debt for ABT at $29.6 billion in Q1 2026, $9.9 billion in Q4 2025, and $11.6 billion in Q3 2025.